home / stock / pavm / pavm news

PAVM News and Press, PAVmed Inc. From 03/08/22

Stock Information
Company Name: PAVmed Inc.
Stock Symbol: PAVM
Market: NASDAQ
Website: pavmed.com
Menu
PAVM PAVM Quote PAVM Short PAVM News PAVM Articles PAVM Message Board
Get PAVM Alerts

News, Short Squeeze, Breakout and More Instantly...
PAVM - PAVmed to Hold a Business Update Conference Call on March 29, 2022

Company conference call and webcast at 4:30 PM EDT PAVmed Inc. (Nasdaq: PAVM, PAVMZ ), a highly differentiated, multi-product, commercial-stage medical device company today announced that the companies will host a business update conference call on Tuesday, March 29, 202...
PAVM - Lucid Diagnostics to Hold a Business Update Conference Call on March 28, 2022

Company conference call and webcast at 4:30 PM EDT Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, a majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ), today announced that the ...

PAVM - Lucid Diagnostics to Participate in the LSI USA '22 Emerging Medtech Summit

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), today announced that Dr. Lishan Aklog, Chairman and CEO, ...

PAVM - PAVmed unit Lucid acquires certain licenses/assets to operate new lab for EsoGuard test

Lucid Diagnostics' (LUCD -4.7%) unit LucidDx Labs acquired certain licenses and other related assets from ResearchDx to operate its own new CLIA-certified, CAP-accredited clinical laboratory located in Lake Forest, California. Lucid — which is a majority-owned subsidiary of P...
PAVM - PAVmed Subsidiary Lucid Diagnostics Launches LucidDx Labs to Accommodate EsoGuard Testing Growth

New wholly owned Lucid subsidiary now performing EsoGuard ® Esophageal DNA Test in its own new state-of-the-art CLIA-certified, CAP-accredited clinical laboratory Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention...

PAVM - PAVmed picks internal candidate for COO role

PAVmed (NASDAQ:PAVM) appointed Shaun O'Neil as EVP & COO, overseeing diverse corporate operations and commercial activities across the company and its subsidiaries. Mr. O’Neil has served as the company's Chief Commercial Officer and EVP, Business Development since joining...

PAVM - PAVmed Appoints Shaun O'Neil as Chief Operating Officer

PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company and parent of cancer prevention company Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”), today announced the appoin...
PAVM - Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors

PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company and parent of cancer prevention company Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) , today announced the a...

PAVM - Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), today announced that Dr. Lishan Aklog, Chairman and CEO, will...

PAVM - NVDA, XLNX and CLOV among pre market gainers

MDJM (NASDAQ:MDJH) +64%. The OLB Group OLB +25% reports $1.35B in transaction value post CBD Merchants acquisition. Advanced Micro Devices AMD +13% on Q4 results. Xilinx (NASDAQ:XLNX) +12%. Capri Holdings CPRI +12% on Q3 results. IceCure Medical (NASDAQ:ICCM) +11%. Arrival...
Previous 10 Next 10